Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes

ConclusionThus, these results suggest that while diabetes is an independent risk factor for COVID-19-related mortality, this risk is dramatically reduced in subjects taking metformin prior to diagnosis of COVID-19, raising the possibility that metformin may provide a protective approach in this high risk population.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research